Article

Handgrip increases endothelin-1 secretion in normotensive young male offspring of hypertensive parents.

Second Division of Cardiology, Institute of Cardiac Surgery, University La Sapienza, Rome, Italy.
Journal of the American College of Cardiology (impact factor: 14.16). 05/1998; 31(6):1362-6. pp.1362-6
Source: PubMed

ABSTRACT We tested the hypothesis that an abnormal response of plasma endothelin-1 (ET-1) is elicited by handgrip exercise (HG) in young normotensive offspring of hypertensive parents.
It has been hypothesized that ET-1 is involved in blood pressure control and plays a pathophysiologic role in the development of clinical hypertension.
Two groups of healthy male subjects, 11 with hypertensive parents (group A) and 10 without a family history of hypertension (group B), underwent 4 min of HG at 50% maximal capacity. Heart rate and blood pressure and plasma levels of ET-1, epinephrine and norepinephrine were measured at baseline, peak HG, and after 2 (R2) and 10 (R10) min of recovery.
Group A had higher norepinephrine levels than group B throughout the test (baseline 181+/-32 [SEM] vs. 96+/-12 pg/ml, p < 0.05; peak HG 467+/-45 vs. 158+/-12 pg/ml, p < 0.000001; R2 293+/-46 vs. 134+/-8 pg/ml, p < 0.01; RO1 214+/-27 vs. 129+/-10 pg/ml, p < 0.0005); no significant difference in epinephrine levels was detected. Compared with group B subjects, group A had higher baseline ET-1 levels (1.07+/-0.14 vs. 0.59+/-0.11 pg/ml, p < 0.02), which increased to a greater extent at peak HG (1.88+/-0.31 vs. 0.76+/-0.09 pg/ml, p < 0.005) and R2 (2.46+/-0.57 vs. 1.31+/-0.23 pg/ml, p < 0.05) and remained elevated at R10 (3.16+/-0.78 vs. 0.52+/-0.09 pg/ml, p < 0.002). Multivariate analysis demonstrated that only a family history of hypertension (chi-square=7.59, p=0.0059) and ET-1 changes during HG (chi-square=4.23, p=0.0398) were predictive of blood pressure response to HG and that epinephrine and norepinephrine were not.
The response to HG in offspring of hypertensive parents produced increased ET-1 plasma levels and resulted in a sustained ET-1 release into the bloodstream during recovery compared with offspring of normotensive parents. This may be an important marker for future clinical hypertension.

0 0
 · 
0 Bookmarks
 · 
34 Views
  • Article: The endothelium and cardiovascular disease--a complex relation.
    New England Journal of Medicine 05/1994; 330(15):1081-3. · 53.30 Impact Factor
  • Article: Endothelin and endothelin antagonism: roles in cardiovascular health and disease.
    [show abstract] [hide abstract]
    ABSTRACT: Endothelin is the most potent mammalian vasoconstrictor yet discovered. Its three isoforms play leading roles in regulating vascular tone and causing mitogenesis. The isoforms bind to two major receptor subtypes (ETA and ETB), which mediate a wide variety of physiologic actions in several organ systems. Endothelin may also be a disease marker or an etiologic factor in ischemic heart disease, atherosclerosis, congestive heart failure, renal failure, myocardial and vascular wall hypertrophy, systemic hypertension, pulmonary hypertension, and subarachnoid hemorrhage. Specific and nonspecific receptor antagonists and ECE inhibitors that have been developed interfere with endothelin's function. Many available cardiovascular therapeutic agents, such as angiotensin-converting-enzyme inhibitors, calcium-entry blocking drugs, and nitroglycerin, also may interfere with endothelin release or may modify its activity. The endothelin antagonists have great potential as agents for use in the treatment of a wide spectrum of disease entities and as biologic probes for understanding the actions of endothelin in human beings.
    American Heart Journal 10/1995; 130(3 Pt 1):601-10. · 4.65 Impact Factor
  • Article: Postural change and volume expansion affect plasma endothelin levels.
    JAMA The Journal of the American Medical Association 03/1990; 263(5):661. · 30.03 Impact Factor

Full-text

View
2 Downloads
Available from

Keywords

4 min
 
50% maximal capacity
 
blood pressure control
 
blood pressure response
 
bloodstream
 
clinical hypertension
 
epinephrine levels
 
ET-1 changes
 
ET-1 plasma levels
 
family history
 
future clinical hypertension
 
group B
 
group B subjects
 
healthy male subjects
 
Heart rate
 
pathophysiologic role
 
peak HG
 
plasma levels
 
sustained ET-1 release
 
young normotensive offspring